Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Migrant Health Research group, Barcelona Institute for Global Health (ISGlobal, University of Barcelona), Barcelona, Spain; CIBERINFEC, (CIBER de Enfermedades Infecciosas), Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain.
Department of Infectious Tropical Diseases and Microbiology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Clin Microbiol Infect. 2023 Dec;29(12):1528-1537. doi: 10.1016/j.cmi.2023.09.010. Epub 2023 Sep 20.
Asymptomatic malaria infections are highly prevalent in endemic areas.
This systematic review aimed to estimate the pooled prevalence of malaria parasites in migrants screened in non-endemic areas.
MEDLINE-Ovid, EMBASE, Web of Science, Global Health, Lilacs, Cochrane, and MedRxiv.
Cross-sectional studies and observational prospective or retrospective cohort studies conducted in Europe, USA, Canada, Australia, or New Zealand regardless of language or publication status. Studies should include prevalence data on malaria in migrants that were recruited through a systematic screening approach. We excluded studies where people were tested because of malaria symptoms.
Migrant individuals exposed to malaria infection ASSESSMENT OF RISK OF BIAS: A standardized and validated appraisal instrument was used for studies reporting prevalence data (Joanna Briggs Institute Manual for Evidence Synthesis).
Pooled estimates of the parasite prevalence by PCR, microscopy, and rapid diagnostic test (RDT) were calculated with a random-effects model. Heterogeneity was explored by stratification by age, region of origin, period of study, and quality of studies.
Of 1819 studies retrieved, 23 studies were included with in total 4203 participant PCR data, 3186 microscopy and 4698 RDT data, respectively. Migrants from sub-Saharan Africa had a malaria parasite prevalence of 8.3% (95% CI 5.1-12.2) by PCR, 4.3% (1.5-8.2) by RDT, and 3.1% (0.7-6.8) by microscopy. For migrants from Asia and Latin America, the prevalence with PCR was 0% (0.0-0.08) and 0.4% (0.0-1.8), respectively. Migrants from the Central African Region had the highest PCR prevalence (9.3% [6.0-13.0]), followed by West African migrants (2.0% [0.0-7.7]). Restricting the analysis to sub-Saharan Africa migrants arriving to the host country within the previous year, the PCR-based prevalence was 11.6% (6.9-17.4).
We provide estimates on the malaria parasite prevalence in migrants in non-endemic setting. Despite heterogeneity between settings, these findings can contribute to inform screening strategies and guidelines targeting malaria in migrants.
无症状疟疾感染在流行地区非常普遍。
本系统评价旨在估计在非流行地区筛查的移民中疟疾寄生虫的总患病率。
MEDLINE-Ovid、EMBASE、Web of Science、全球卫生、Lilacs、Cochrane 和 MedRxiv。
在欧洲、美国、加拿大、澳大利亚或新西兰进行的横断面研究和观察性前瞻性或回顾性队列研究,无论语言或出版状态如何。这些研究应包括通过系统筛查方法招募的移民中疟疾患病率的数据。我们排除了因疟疾症状而接受检测的人群的研究。
接触过疟疾感染的移民
使用标准化和验证的评估工具评估报告患病率数据的研究(Joanna Briggs 研究所证据综合手册)。
使用随机效应模型计算聚合估计的寄生虫患病率,聚合估计的寄生虫患病率来自 PCR、显微镜和快速诊断检测(RDT)。通过分层分析年龄、原籍地区、研究期间和研究质量来探索异质性。
在检索到的 1819 项研究中,有 23 项研究被纳入,共纳入 4203 名参与者的 PCR 数据、3186 名参与者的显微镜和 4698 名参与者的 RDT 数据。来自撒哈拉以南非洲的移民通过 PCR 的疟疾寄生虫患病率为 8.3%(95%CI 5.1-12.2),通过 RDT 的患病率为 4.3%(1.5-8.2),通过显微镜的患病率为 3.1%(0.7-6.8)。来自亚洲和拉丁美洲的移民,通过 PCR 的患病率分别为 0%(0.0-0.08)和 0.4%(0.0-1.8)。来自中非地区的移民的 PCR 患病率最高(9.3%[6.0-13.0]),其次是西非移民(2.0%[0.0-7.7])。将分析仅限于在过去一年内在宿主国家抵达的撒哈拉以南非洲移民,基于 PCR 的患病率为 11.6%(6.9-17.4)。
我们提供了非流行地区移民中疟疾寄生虫患病率的估计值。尽管不同环境之间存在异质性,但这些发现有助于为针对移民的疟疾筛查策略和指南提供信息。